tiprankstipranks
Zimmer Biomet Holdings (MX:ZBH)
:ZBH
Mexico Market
ZBH
Zimmer Biomet Holdings
RESEARCH TOOLSreports

Zimmer Biomet Holdings (ZBH) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

ZBH Analyst Ratings

Moderate Buy
10Ratings
Moderate Buy
4 Buy
6 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Zimmer
Biomet Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ZBH Stock 12 Month Forecast

Average Price Target

$1,738.20
▲(15.73% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Zimmer Biomet Holdings in the last 3 months. The average price target is $1,738.20 with a high forecast of $2,007.86 and a low forecast of $1,449.15. The average price target represents a 15.73% change from the last price of $1,502.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1363":"$1,363","2128":"$2,128","1554.25":"$1,554.3","1745.5":"$1,745.5","1936.75":"$1,936.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2007.8568313,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$2.01K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1738.2026288355555,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.74K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1449.14884346,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.45K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1363,1554.25,1745.5,1936.75,2128],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1502,1540.912063946154,1579.8241278923076,1618.7361918384615,1657.6482557846155,1696.5603197307692,1735.472383676923,1774.384447623077,1813.296511569231,1852.2085755153846,1891.1206394615385,1930.0327034076922,1968.9447673538461,{"y":2007.8568313,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1502,1520.1694329873503,1538.3388659747009,1556.5082989620512,1574.6777319494017,1592.847164936752,1611.0165979241026,1629.186030911453,1647.3554638988035,1665.5248968861538,1683.6943298735043,1701.8637628608546,1720.0331958482052,{"y":1738.2026288355555,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1502,1497.93452642,1493.86905284,1489.80357926,1485.73810568,1481.6726321,1477.60715852,1473.54168494,1469.47621136,1465.41073778,1461.3452642,1457.27979062,1453.21431704,{"y":1449.14884346,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2123.426,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2123.426,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2123.426,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2127.791,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1745.88,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1634.778,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1639.059,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1639.059,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1639.059,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1644.372,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1364.669,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1364.669,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1502,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$2,008Average Price Target$1,738Lowest Price Target$1,449
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on MX:ZBH
Patrick Wood
UBS
UBS
$1,553.91→$2,007.86
Buy
33.68%
Upside
Upgraded
07/28/26
BTIG Analyst forecast on MX:ZBH
Ryan Zimmerman
BTIG
BTIG
―
Hold
―
Reiterated
07/23/26
Zimmer Biomet: Solid Orthopedics Franchise and Early-Stage Digital Investments Support Neutral Risk-Reward, Justifying Hold Rating
RBC Capital Analyst forecast on MX:ZBH
Shagun Singh Chadha
RBC Capital
RBC Capital
$1,763.42
Buy
17.40%
Upside
Reiterated
07/13/26
Zimmer Biomet Holdings (ZBH) Receives a Buy from RBC Capital
BMO Capital Analyst forecast on MX:ZBH
Vik Chopra
BMO Capital
BMO Capital
$1,658.66
Hold
10.43%
Upside
Initiated
07/09/26
Zimmer Biomet Kept at Hold as Analyst Awaits Proof of Salesforce Overhaul, Margin Stability and Robotics‑Driven Upside
Citi Analyst forecast on MX:ZBH
Joanne Wuensch
Citi
Citi
$1,623.75
Hold
8.11%
Upside
Reiterated
07/08/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Tvardi Therapeutics (NASDAQ: TVRD), Resmed (NYSE: RMD) and Zimmer Biomet Holdings (NYSE: ZBH)
Evercore ISI Analyst forecast on MX:ZBH
Vijay Kumar
Evercore ISI
Evercore ISI
$2,095.15→$1,920.56
Buy
27.87%
Upside
Reiterated
07/06/26
Zimmer Biomet price target lowered to $110 from $120 at Evercore ISIZimmer Biomet price target lowered to $110 from $120 at Evercore ISI
Canaccord Genuity Analyst forecast on MX:ZBH
Caitlin Roberts
Canaccord Genuity
Canaccord Genuity
$1,449.15
Hold
-3.52%
Downside
Reiterated
06/30/26
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Compass Therapeutics (NASDAQ: CMPX) and 10x Genomics (NASDAQ: TXG)
TD Cowen Analyst forecast on MX:ZBH
Mathew Blackman
TD Cowen
TD Cowen
$1,903.1
Buy
26.70%
Upside
Reiterated
06/25/26
Analysts' Top Healthcare Picks: Codexis (CDXS), Zimmer Biomet Holdings (ZBH)
Bank of America Securities Analyst forecast on MX:ZBH
Travis Steed
Bank of America Securities
Bank of America Securities
$1,745.96
Hold
16.24%
Upside
Reiterated
06/12/26
Zimmer Biomet Holdings (ZBH) Receives a Hold from Bank of America Securities
Wells Fargo Analyst forecast on MX:ZBH
Larry Biegelsen
Wells Fargo
Wells Fargo
$1,571.37
Hold
4.62%
Upside
Assigned
06/01/26
Wells Fargo Gives a Hold Rating to Zimmer Biomet Holdings (ZBH)
William Blair Analyst forecast on MX:ZBH
Steven Lichtman
William Blair
William Blair
―
Hold
―
Reiterated
04/29/26
Zimmer Biomet: Hold Reiterated as Execution Risks, Salesforce Transition, and CFO Departure Offset Q1 Beat and Margin Upside
Robert W. Baird Analyst forecast on MX:ZBH
Jeff Johnson
Robert W. Baird
Robert W. Baird
$1,745.96→$1,606.29
Hold
6.94%
Upside
Reiterated
04/29/26
Zimmer Biomet price target lowered to $92 from $100 at BairdZimmer Biomet price target lowered to $92 from $100 at Baird
Truist Financial Analyst forecast on MX:ZBH
Richard Newitter
Truist Financial
Truist Financial
$1,711.04→$1,606.29
Hold
6.94%
Upside
Reiterated
04/29/26
Zimmer Biomet Holdings (ZBH) Receives a Hold from Truist Financial
J.P. Morgan Analyst forecast on MX:ZBH
Robbie Marcus
J.P. Morgan
J.P. Morgan
$1,745.96→$1,658.66
Hold
10.43%
Upside
Reiterated
04/29/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC), Zimmer Biomet Holdings (NYSE: ZBH) and Qiagen (NYSE: QGEN)
Barclays Analyst forecast on MX:ZBH
Matt Miksic
Barclays
Barclays
$1,745.96→$1,641.2
Sell
9.27%
Upside
Reiterated
04/29/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Radnet (NASDAQ: RDNT), Centene (NYSE: CNC) and Zimmer Biomet Holdings (NYSE: ZBH)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on MX:ZBH
Patrick Wood
UBS
UBS
$1,553.91→$2,007.86
Buy
33.68%
Upside
Upgraded
07/28/26
BTIG Analyst forecast on MX:ZBH
Ryan Zimmerman
BTIG
BTIG
―
Hold
―
Reiterated
07/23/26
Zimmer Biomet: Solid Orthopedics Franchise and Early-Stage Digital Investments Support Neutral Risk-Reward, Justifying Hold Rating
RBC Capital Analyst forecast on MX:ZBH
Shagun Singh Chadha
RBC Capital
RBC Capital
$1,763.42
Buy
17.40%
Upside
Reiterated
07/13/26
Zimmer Biomet Holdings (ZBH) Receives a Buy from RBC Capital
BMO Capital Analyst forecast on MX:ZBH
Vik Chopra
BMO Capital
BMO Capital
$1,658.66
Hold
10.43%
Upside
Initiated
07/09/26
Zimmer Biomet Kept at Hold as Analyst Awaits Proof of Salesforce Overhaul, Margin Stability and Robotics‑Driven Upside
Citi Analyst forecast on MX:ZBH
Joanne Wuensch
Citi
Citi
$1,623.75
Hold
8.11%
Upside
Reiterated
07/08/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Tvardi Therapeutics (NASDAQ: TVRD), Resmed (NYSE: RMD) and Zimmer Biomet Holdings (NYSE: ZBH)
Evercore ISI Analyst forecast on MX:ZBH
Vijay Kumar
Evercore ISI
Evercore ISI
$2,095.15→$1,920.56
Buy
27.87%
Upside
Reiterated
07/06/26
Zimmer Biomet price target lowered to $110 from $120 at Evercore ISIZimmer Biomet price target lowered to $110 from $120 at Evercore ISI
Canaccord Genuity Analyst forecast on MX:ZBH
Caitlin Roberts
Canaccord Genuity
Canaccord Genuity
$1,449.15
Hold
-3.52%
Downside
Reiterated
06/30/26
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Compass Therapeutics (NASDAQ: CMPX) and 10x Genomics (NASDAQ: TXG)
TD Cowen Analyst forecast on MX:ZBH
Mathew Blackman
TD Cowen
TD Cowen
$1,903.1
Buy
26.70%
Upside
Reiterated
06/25/26
Analysts' Top Healthcare Picks: Codexis (CDXS), Zimmer Biomet Holdings (ZBH)
Bank of America Securities Analyst forecast on MX:ZBH
Travis Steed
Bank of America Securities
Bank of America Securities
$1,745.96
Hold
16.24%
Upside
Reiterated
06/12/26
Zimmer Biomet Holdings (ZBH) Receives a Hold from Bank of America Securities
Wells Fargo Analyst forecast on MX:ZBH
Larry Biegelsen
Wells Fargo
Wells Fargo
$1,571.37
Hold
4.62%
Upside
Assigned
06/01/26
Wells Fargo Gives a Hold Rating to Zimmer Biomet Holdings (ZBH)
William Blair Analyst forecast on MX:ZBH
Steven Lichtman
William Blair
William Blair
―
Hold
―
Reiterated
04/29/26
Zimmer Biomet: Hold Reiterated as Execution Risks, Salesforce Transition, and CFO Departure Offset Q1 Beat and Margin Upside
Robert W. Baird Analyst forecast on MX:ZBH
Jeff Johnson
Robert W. Baird
Robert W. Baird
$1,745.96→$1,606.29
Hold
6.94%
Upside
Reiterated
04/29/26
Zimmer Biomet price target lowered to $92 from $100 at BairdZimmer Biomet price target lowered to $92 from $100 at Baird
Truist Financial Analyst forecast on MX:ZBH
Richard Newitter
Truist Financial
Truist Financial
$1,711.04→$1,606.29
Hold
6.94%
Upside
Reiterated
04/29/26
Zimmer Biomet Holdings (ZBH) Receives a Hold from Truist Financial
J.P. Morgan Analyst forecast on MX:ZBH
Robbie Marcus
J.P. Morgan
J.P. Morgan
$1,745.96→$1,658.66
Hold
10.43%
Upside
Reiterated
04/29/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC), Zimmer Biomet Holdings (NYSE: ZBH) and Qiagen (NYSE: QGEN)
Barclays Analyst forecast on MX:ZBH
Matt Miksic
Barclays
Barclays
$1,745.96→$1,641.2
Sell
9.27%
Upside
Reiterated
04/29/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Radnet (NASDAQ: RDNT), Centene (NYSE: CNC) and Zimmer Biomet Holdings (NYSE: ZBH)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zimmer Biomet Holdings

3 Months
Danielle AntalffyUBS
Success Rate
12/17 ratings generated profit
71%
Average Return
+0.91%
Copying Danielle Antalffy's trades and holding each position for 3 Months would result in 70.59% of your transactions generating a profit, with an average return of +0.91% per trade.
1 Year
Danielle AntalffyUBS
Success Rate
12/17 ratings generated profit
71%
Average Return
+4.48%
Copying Danielle Antalffy's trades and holding each position for 1 Year would result in 70.59% of your transactions generating a profit, with an average return of +4.48% per trade.
2 Years
Danielle AntalffyUBS
Success Rate
13/17 ratings generated profit
76%
Average Return
+9.42%
Copying Danielle Antalffy's trades and holding each position for 2 Years would result in 76.47% of your transactions generating a profit, with an average return of +9.42% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZBH Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
13
11
7
6
5
Hold
15
21
16
17
10
Sell
5
4
1
1
0
Strong Sell
0
0
0
0
0
total
33
36
24
24
15
In the current month, ZBH has received 5 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. ZBH average Analyst price target in the past 3 months is 1,738.20.
Each month's total comprises the sum of three months' worth of ratings.

ZBH Financial Forecast

ZBH Earnings Forecast

Next quarter’s earnings estimate for ZBH is $35.06 with a range of $34.53 to $35.75. The previous quarter’s EPS was $36.45. ZBH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.32% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.
Next quarter’s earnings estimate for ZBH is $35.06 with a range of $34.53 to $35.75. The previous quarter’s EPS was $36.45. ZBH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.32% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.

ZBH Sales Forecast

Next quarter’s sales forecast for ZBH is $37.23B with a range of $36.97B to $37.71B. The previous quarter’s sales results were $36.39B. ZBH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 30.43% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.
Next quarter’s sales forecast for ZBH is $37.23B with a range of $36.97B to $37.71B. The previous quarter’s sales results were $36.39B. ZBH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 30.43% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.

ZBH Stock Forecast FAQ

What is MX:ZBH’s average 12-month price target, according to analysts?
Based on analyst ratings, Zimmer Biomet Holdings’s 12-month average price target is 1,738.20.
    What is MX:ZBH’s upside potential, based on the analysts’ average price target?
    Zimmer Biomet Holdings has 15.73% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Zimmer Biomet Holdings a Buy, Sell or Hold?
          Zimmer Biomet Holdings has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 6 hold ratings and 0 sell ratings.
            What is Zimmer Biomet Holdings’s share price target?
            The average share price target for Zimmer Biomet Holdings is 1,738.20. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $2,007.86 ,and the lowest forecast is $1,449.15. The average share price target represents 15.73% Increase from the current price of $1,502.
              What do analysts say about Zimmer Biomet Holdings?
              Zimmer Biomet Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of Zimmer Biomet Holdings?
                To buy shares of MX:ZBH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.